Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial by Sabina A. Murphy, Elliott M. Antman, Stephen D. Wiviott, Govinda Weerakkody, Giorgio Morocutti, Kurt Huber, Jose Lopez-Sendon, Carolyn H. McCabe, and Eugene Braunwald EHJ Volume 29(20): October 14, 2008 Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please
Additional primary endpoint events by randomized therapy. Sabina A. Murphy et al. Eur Heart J 2008;29: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please
(A) Landmark analysis of time from first event to second event by randomized therapy. Sabina A. Murphy et al. Eur Heart J 2008;29: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please
Subsequent primary events during follow-up by randomized therapy among subgroups. Sabina A. Murphy et al. Eur Heart J 2008;29: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please